In the present study, we investigated the potential of CMKLR1-targeted PET to monitor the kinetics of MDMφ accumulation in a murine model of fibrotic lung injury and to determine the clinical relevance of CMKLR1 as a biomarker for endotyping and prognostication of fibrotic lung diseases. Here, CMKLR1 is linked to lung disorder.